Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208819 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00208819: Completed Phase 4 study, sponsored by Emory University.
NCT00208819 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00208819, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an antipsychotic medication alone or an antipsychotic medication in combination with divalproex is the most effective and safest way to treat agitation in elderly patients with dementia.
Interventions
- DRUG risperidone
- DRUG olanzapine
- DRUG quetiapine
- DRUG divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
What the finished NCT00208819 record still lists
NCT00208819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which risperidone is the first listed.
NCT00208819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00208819 about?
NCT00208819 is a clinical study titled "A Comparison of Two Standard Therapies in the Management of Dementia With Agitation". The purpose of this study is to determine whether an antipsychotic medication alone or an antipsychotic medication in combination with divalproex is the most effective and safest way to treat agitation in elderly patients with dementia.
What is the current status of trial NCT00208819?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2003-09. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00208819?
The interventions under investigation include: risperidone (DRUG), olanzapine (DRUG), quetiapine (DRUG), divalproex (DRUG).
Who is sponsoring clinical trial NCT00208819?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00208819's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia